Zacks Research Has Positive Outlook of MD FY2026 Earnings

Pediatrix Medical Group, Inc. (NYSE:MD) – Zacks Research upped their FY2026 earnings per share (EPS) estimates for shares of Pediatrix Medical Group in a report issued on Monday, March 10th. Zacks Research analyst Z. Masood now forecasts that the company will post earnings of $1.44 per share for the year, up from their prior estimate of $1.43. The consensus estimate for Pediatrix Medical Group’s current full-year earnings is $1.38 per share.

Several other equities research analysts have also commented on the company. UBS Group upped their target price on Pediatrix Medical Group from $16.50 to $18.50 and gave the company a “neutral” rating in a research report on Friday, February 21st. Mizuho upped their target price on Pediatrix Medical Group from $13.00 to $15.00 and gave the company a “neutral” rating in a research report on Tuesday, November 19th. Truist Financial upped their target price on Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research report on Friday, February 21st. Macquarie assumed coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They set an “outperform” rating and a $18.00 target price on the stock. Finally, StockNews.com upgraded Pediatrix Medical Group from a “hold” rating to a “buy” rating in a report on Wednesday, January 22nd. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Pediatrix Medical Group currently has a consensus rating of “Hold” and an average target price of $17.08.

Pediatrix Medical Group Stock Down 1.2 %

Shares of Pediatrix Medical Group stock opened at $13.75 on Thursday. Pediatrix Medical Group has a one year low of $6.62 and a one year high of $17.67. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.60 and a quick ratio of 1.42. The stock’s 50-day moving average is $14.13 and its 200 day moving average is $13.38. The firm has a market cap of $1.18 billion, a price-to-earnings ratio of -11.46, a PEG ratio of 1.74 and a beta of 1.48.

Pediatrix Medical Group (NYSE:MD) last announced its earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The company had revenue of $502.36 million for the quarter, compared to analyst estimates of $486.22 million.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Nomura Asset Management Co. Ltd. raised its stake in shares of Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock worth $33,000 after purchasing an additional 1,220 shares during the last quarter. Quest Partners LLC raised its stake in shares of Pediatrix Medical Group by 25.6% in the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after purchasing an additional 622 shares during the last quarter. Parkside Financial Bank & Trust raised its stake in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock worth $51,000 after purchasing an additional 1,040 shares during the last quarter. Quarry LP raised its stake in shares of Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after purchasing an additional 1,662 shares during the last quarter. Finally, AlphaQuest LLC raised its stake in shares of Pediatrix Medical Group by 65.9% in the fourth quarter. AlphaQuest LLC now owns 5,066 shares of the company’s stock worth $66,000 after purchasing an additional 2,012 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.